参考文献/References:
［1］ QIN J，LI R，RAES J，et al.A human gut microbial gene catalogue established by metagenomic sequencing［J］.Nature,2010,464（7285）：59-65.
［2］ 陈玉霞，詹学.肠道菌群和炎症性肠病［J］.中华临床医师杂志，2014,8（8）:1561-1566.
［3］ 刘重阳，陈东.肠道菌群在炎症性肠病发病中的作用［J］.重庆医学，2009，38(10)：1251-1253.
［4］ 周国华.末端回肠炎的基础与研究［M］.北京：人民军医出版社，2008：90.
［5］ RANA S,BHANSALI A,BHADADA S,et al.Orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetes patients from North India［J］.Diabetes Technol Ther，2011,13(11):1115-1120.
［6］ BARMAN M,UNOLD D,SHIFLEY K,et al.Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract［J］.Infect Immun，2008,76(3):907-915.
［7］ RIDLON J M,KANG D J,HYLEMON P B.Bile salt biotransformations by human intestinal bacteria［J］.J Lipid Res，2006,47(2):241-259.
［8］ SELLERS R S,MORTON D.The colon:from banal to brilliant［J］.Toxicol Pathol，2014,42(1):67-81
［9］ SUN Y,ZHANG M,CHEN C C,et al.Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice［J］.Gastroenterology，2013,144(7):1478-1487.
［10］ LADIRAT S E,SCHOLS H A,NAUTA A,et al.High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition［J］.J Microbiol Methods，2013,92(3):387-397.
［11］ REHMAN A,HEINSEN F A,KOENEN M E,et al.Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine［J］.BMC Microbiol，2012,12:47.
［12］ LANE J A,MEHRA R K,CARRINGTON S D,et al.The food glycome:a source of protection against pathogen colonization in the gastrointestinal tract［J］.Int J Food Microbiol，2010,142(1/2):1-13.
［13］ 王玉玲，甘兰庄，吕志红.肠道菌群失调在功能性腹泻的临床研究［J］.山西医药杂志，2010,39（2）:176-177.
［14］ BURES J,CYRANY J,KOHOUTOVA D,et al.Small intestinal bacterial overgrowth syndrome［J］.World J Gastroenterol,2010,16(24)：2978-2990.
［15］ BONDARCNKO V M,LYKOVA E A,MATSULCVICH T V,et al.Microccological aspects of small intestinal bacterial overgrowth syndrome［J］.Zh Mikrobiol Epdcmiol Immunobiol,2006(6):57-63.
［16］ 马永健，莫远圣，曹掌歧.呼气氢测试仪的研究与临床应用［J］.现代科学仪器，2004,20（6）:18-21.
［17］ POSSERUD I，STOTZER P O，BJORNSSON E S，et al.Small intestinal bacterial overgrowth in patients with irritable bowel syndrome［J］.Gut,2007,56(6):802-808.
［18］ FORD A C，SPIEGEL B M，TALLEY N J，et al.Small intestinal bacterial overgrowth in irritable bowel syndrome:systematic review and meta-analysis［J］.Clin Gastroenterol Hepatol,2009,7(12):1279-1286.
［19］ FRIED M,SIEGRIST H,FREI R,et al.Duodenal bacterial overgrowth during treatment in outpatients with omeprazole［J］.Gut，1994,35(1):23-26
［20］ LOMBARDO L,FOTI M,RUGGIA O,et al.Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy［J］.Clin Gastroenterol Hepatol，2010，8(6):504-508.
［21］ JACOBS C,COSS ADAME E,ATTALURI A,et al.Dysmotility and proton pump inhibitor use are independent risk factor for small intestinal bacterial and/or fungal overgrowth［J］.Aliment Pharmacol Ther，2013，37(11):1103-1111.
［22］ 王凯.质子泵抑制剂与小肠细菌过度生长关系的探讨［J］.临床医学,2014,34（5）:41-42.
［23］ RATUAPLI S K,ELLINGTON T G,ONEILL M T,et al.Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth［J］.Am J Gastroenterol,2012,107(5):730-735.
［24］ LO W K,CHAN W W.Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth：a meta-analysis［J］.Clin Gastroenterol Hepatol,2013,11(5):483-490.
［25］ CHUNG R S,RUFF K C,MALHOTRA A,et al.Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture［J］.Aliment Pharmacol Ther,2011,33(12):1378-1379.
［26］ DEL PIANO M,ANDERLONI A,BALZARINI M,et al.The innovative potential of Lactobacillus rhamnosus LR06,Lactobacillus pentosus LPS01,Lactobacillus plantarum LP01,and Lactobacillus delbrueckii Subsp.delbrueckii LDD01 to restore the "gastric barrier effect" in patients chronically treated with PPI:a pilot study［J］.J Clin Gastroenterol,2012,46(Suppl):S18-S26.
［27］ 魏艳荣.十二指肠球部溃疡并出血与小肠细菌过度生长关系探讨［J］.现代中西医结合杂志，2013,22（19）:2114-2115.
［28］ 周绵，王爱民，江景坤，等.幽门螺杆菌相关性消化性溃疡与小肠细菌过度生长的关系［J］.胃肠病学与肝病学杂志，2013,22(1):60-61.
［29］ MURAKI M,FUJIWARA Y,MACHIDA H,et al.Role of small intestinal bacterial overgrowth in severe small intestinal damage in chronic non-steroidal anti-inflammatory drug users［J］.Scand J Gastroenterol,2014,49(3):267-273.
［30］ LAINE L,AHNEN D,MCCLAIN C,et al.Review article:potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors［J］.Aliment Pharmacol Ther,2000,14(6):651-668.
［31］ SANDULEANU S,JONKERS D,DE BRUINE A,et al.Non-helicobacter pylori bacterial flora during acid-suppressive therapy:differential findings in gastric juice and gastric mucosa［J］.Aliment Pharmacol Ther,2001,15(3):379-388.
［32］ WILLIAMS C,MCCOLL K E.Review article:proton pump inhibitors and bacterial overgrowth［J］.Aliment Pharmacol Ther,2006,23（1）:3-10.
［33］ HUSEBYE E.The pathogenesis of gastrointestinal bacterial overgrowth［J］.Chemotherapy,2005,51(1):1-22.
［34］ EVENEPOEL P,CLAUS D,GEYPENS B,et al.Evidence for impaired assimilation and increased colonic fermentation of protein,related to gastric acid suppression therapy［J］.Aliment Pharmacol Ther,1998,12(10):1011-1019.
［35］ PARKMAN H P,URBAIN J L,KNIGHT L C,et al.Effect of gastric acid suppressants on human gastric motility［J］.Gut,1998,42(2):243-250.
［36］ GODDARD A F,SPILLER R C.The effect of omeprazole on gastric juice viscosity,pH and bacterial counts［J］.Aliment Pharmacol Ther,1996,10(1):105-109.
［37］ YOSHIDA N,YOSHIKAWA T,TANAKA Y,et al.A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions［J］.Aliment Pharmacol Ther,2000,14(Suppl 1):74-81.
相似文献/References:
[1]王 超,袁 宇.冠状动脉粥样硬化性心脏病患者肠道菌群丰度与血脂和血尿酸水平的相关性[J].新乡医学院学报,2019,36(7):623.[doi:10.7683/xxyxyxb.2019.07.006]
WANG Chao,YUAN Yu.Correlation between gut flora abundance and blood lipid,blood uric acid levels in patients with coronary atherosclerotic heart disease[J].Journal of Xinxiang Medical University,2019,36(4):623.[doi:10.7683/xxyxyxb.2019.07.006]
[2]何 艳,金孝岠.围手术期患者肠道菌群失调相关因素及其与术后并发症的关系研究进展[J].新乡医学院学报,2021,38(8):790.[doi:10.7683/xxyxyxb.2021.08.018]
[3]石 翠,袁 宇.冠状动脉性心脏病患者肠道菌群数量与血脂及同型半胱氨酸水平的相关性[J].新乡医学院学报,2021,38(1):044.[doi:10.7683/xxyxyxb.2021.01.009]
SHI Cui,YUAN Yu.Correlation between the amount of the intestinal flora and blood lipid,homocysteine levels in patients with coronary heart disease[J].Journal of Xinxiang Medical University,2021,38(4):044.[doi:10.7683/xxyxyxb.2021.01.009]
[4]杜鹏程,韩 璠,谷九莲.溃疡性结肠炎患者血清单核细胞趋化蛋白-1、高迁移率族蛋白B1、肿瘤坏死因子-α、白细胞介素-6和白细胞介素-10水平与肠道菌群的相关性[J].新乡医学院学报,2021,38(4):370.[doi:10.7683/xxyxyxb.2021.04.016]
DU Pengcheng,HAN Fan,GU Jiulian.Correlation between serum monocyte chemoattractant protein-1,high mobility group protein B1,tumor necrosis factor-α,interleukin-6,interleukin-10 levels and intestinal flora in patients with ulcera-tive colitis[J].Journal of Xinxiang Medical University,2021,38(4):370.[doi:10.7683/xxyxyxb.2021.04.016]
[5]王会敏,韩际奥",徐于平,等.利福昔明治疗乙型肝炎肝硬化腹水疗效观察[J].新乡医学院学报,2021,38(9):842.[doi:10.7683/xxyxyxb.2021.09.009]
WANG Huimin,HAN Jiao,XU Yuping,et al.Curative effect of rifaximin in the treatment of hepatitis B related cirrhosis and ascites[J].Journal of Xinxiang Medical University,2021,38(4):842.[doi:10.7683/xxyxyxb.2021.09.009]
[6]王 洁,谢国旗,倪 军,等.2型糖尿病与肠道菌群失衡关系研究进展[J].新乡医学院学报,2020,37(6):597.[doi:10.7683/xxyxyxb.2020.06.022]
[7]陈芳玮,梁彦超,廖 亮,等.慢性阻塞性肺疾病患者肠道菌群分布、血浆N端脑钠肽前体和D-二聚体水平及其合并肺栓塞的相关危险因素分析[J].新乡医学院学报,2020,37(11):1065.[doi:10.7683/xxyxyxb.2020.11.015]
CHEN Fangwei,LIANG Yanchao,LIAO Liang,et al.Distribution of intestinal flora,plasma levels of N-terminal brain natriuretic peptide precursor and D-dimer in patients with chronic obstructive pulmonary disease and the related risk factors of complicating with pulmonary embolism[J].Journal of Xinxiang Medical University,2020,37(4):1065.[doi:10.7683/xxyxyxb.2020.11.015]
[8]李蒙蒙,王 佩.缺血性脑卒中与肠道菌群失调的关系研究进展[J].新乡医学院学报,2019,36(2):190.[doi:10.7683/xxyxyxb.2019.02.023]
[9]熊万成,张玉松,赫 鹏.慢性传输型便秘患者肠道微生态特点及结肠次全切除术效果分析[J].新乡医学院学报,2018,35(9):813.[doi:10.7683/xxyxyxb.2018.09.016]
XIONG Wan-cheng,ZHANG Yu-song,HE Peng.Characteristics of intestinal microecology and the effect of subtotal colectomy in patients with slow transit constipation[J].Journal of Xinxiang Medical University,2018,35(4):813.[doi:10.7683/xxyxyxb.2018.09.016]
[10]朱佳丽,鲁素彩.小檗碱治疗溃疡性结肠炎研究进展[J].新乡医学院学报,2022,39(2):187.[doi:10.7683/xxyxyxb.2022.02.018]
ZHU Jiali,LU Sucai.Research progress of berberine in the treatment of ulcerative colitis[J].Journal of Xinxiang Medical University,2022,39(4):187.[doi:10.7683/xxyxyxb.2022.02.018]